BGI Genomics: Controlling shareholder proposes company to repurchase shares worth 250 million - 500 million yuan
BGI Genomics' controlling shareholder, BGI Tech Holdings, has proposed a share buyback program for the company. The proposed buyback would range from 250 million to 500 million yuan, to be funded by the company's own capital. This proposal comes amidst a broader market trend where institutional investors are actively trading stocks, with significant net buying and selling observed across various companies. AI
IMPACT This news pertains to corporate finance and stock market activity, with no direct impact on AI operations or development.